ter Haar, Elke L. M., et al. “Efficacy and Safety of Tildrakizumab in Older Patients: Pooled Analyses of Two Randomized Phase III Clinical Trials (reSURFACE 1 and ReSURFACE 2) Through 244 Weeks”. Acta Dermato-Venereologica, vol. 103, Oct. 2023, p. adv17752, doi:10.2340/actadv.v103.17752.